Rare diseases
Investigational molecules
Locations
Back to Spain65 clinical trials in Pontevedra, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa
SpainA Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa
SpainA study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease
SpainStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
SpainComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
SpainStudy on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa
SpainStudy on the Safety and Effectiveness of Elafibranor for Adults with Primary Sclerosing Cholangitis
SpainStudy on Elafibranor for Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid
SpainLong-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen
SpainStudy on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)
SpainStudy on Safety and Efficacy of Bepirovirsen and Drug Combination for Chronic Hepatitis B in Patients on Nucleos(t)ide Analogue Therapy
SpainStudy on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection
SpainThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on tuberculosis treatments, including innovative approaches for both latent and active forms of the disease in special patient populations.
Research evaluating the effectiveness of various rifamycin-based regimens and high-dose antibiotic combinations.
Extensive research into liver diseases, particularly focusing on non-alcoholic steatohepatitis (NASH) and chronic hepatitis B treatments.
Multiple studies evaluating novel therapeutic approaches and combination treatments for liver conditions.
Innovative research in inflammatory skin conditions and immune-mediated disorders, including studies on atopic dermatitis and urticaria.
Investigation of new targeted therapies and dose optimization studies for various skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
